Press Releases
January 29th, 2023 - Rockville, Maryland, USA - OriGene is excited to announce that it has been selected as the 2023 Bioz Stars Award Winner in the following categories: Cloning, Vectors, & CRISPR. In the cloning.
Jan 7th, 2022 - Rockville, Maryland, USA - OriGene updates its logo, signifying its evolvement from genomic to proteomic market. The logo modification includes an addition of antibody/antigen image to the previous logo.
November 21, 2016 - Rockville, Maryland, USA - OriGene Technologies, a large supplier of genecentric research tools, today announced that it has entered into a multi-year strategic agreement with EdiGene (Beijing, China) to develop genome wide knockout cells from commonly used laboratory cell lines.
April 14, 2016 - Rockville, Maryland, USA - A pair of recently published studies shed light on the highly interesting area on detection of ALK expression among NSCLC patients by IHC. One study was conducted by NordiQC (Aalborg, Denmark).
April 14, 2016 - Rockville, Maryland, USA - OriGene Technologies, Inc., announced today that it has entered into a multi-year antibody development collaboration featuring its proprietary UltraMAB® technology platform and granted to Dako, an Agilent Technologies company (Santa Clara, CA), a worldwide non-exclusive commercial license to OriGene’s mouse anti-ALK monoclonal antibody clone OTI1A4 for research and diagnostics use within the immunocytochemistry and immunohistochemistry fields.
Rockville, MD – January 7th, 2016 - OriGene Technologies, Inc. (OriGene), a leading manufacturer of high quality antibodies and gene-centric tools, announced today that they have been awarded a Phase II SBIR contract from the National Cancer Institute (NCI) to develop high-affinity, anti-peptide antibodies for mass-spectrometry-based serum biomarker detection/ quantification assays.
Rockville, MD – Oct 28, 2015 – OriGene Technologies, Inc. (“OriGene”), an industry leader of genome wide products for research and diagnostic applications, announced today that it has acquired Acris Antibodies GmbH (“Acris Antibodies”), a provider of antibodies and other life science related products.
Newark, DE– Oct 28, 2015 – OriGene Technologies, Inc. (“OriGene”), an industry leader of genome wide products for research and diagnostic applications, announced today that it has acquired Acris Antibodies GmbH (“Acris Antibodies”), a provider of antibodies and other life science related products.
Rockville, MD– Feb 26, 2014 – OriGene Technologies, Inc. (“OriGene”),one of the industry leaders in producing genome wide products for research and diagnostic applications, announced today that it has acquired BioCheck, Inc, a provider of innovative immunodiagnostic test kits and custom immunoassay development for the world-wide health care and research markets.
Rockville, MD– Jan 30, 2014 – OriGene Technologies, Inc. (“OriGene”), one of the industry leaders in producing genome wide products for research and diagnostic applications, has been awarded a contract from the National Cancer Institute (NCI) to develop high affinity anti-peptide antibodies for SISCAPA assays.
Rockville, MD. May 30th, 2013 - Scientists from Peking University, China and OriGene Technologies jointly published that multiple lineage specifier genes can replace OCT4 and SOX2 during reprogramming, the core regulators of cell pluripotency.